Corneal Cross-Linking
Corneal cross-linking (CXL) is an in-office procedure designed to strengthen the cornea (the clear, outer lens on the front of the eye) when it has become weakened by laser vision correction surgery or an eye condition called keratoconus. The procedure uses ultraviolet (UV) light and special eye drops containing vitamin B2 to strengthen the cornea. Much like rebar provides strength to concrete, cross-linking provides strength to the cornea by creating connections within the cornea.
The two basic types of corneal cross-linking are:
- Epithelium-off: The thin outer layer (epithelium) of the cornea is removed to allow the vitamin B2 drops to more easily penetrate the corneal tissue. This is the only FDA-approved type of CXL.
- Epithelium-on (or transepithelial CXL): The epithelium of the cornea is left intact and requires a longer period of time for the vitamin B2 drops to be absorbed into the corneal tissue. This type of cross-linking is not FDA-approved but is being studied in clinical trials to determine its effectiveness.
CXL has been found to be highly effective in preventing the progression of keratoconus and post-refractive surgery corneal weakening. In fact, patients who undergo CXL typically see their vision improve by a few lines on the eye chart. The procedure carries little risk, and the benefits are significant. UAB Callahan Eye Hospital is excited to offer this procedure to patients who need it.
Why UAB
Callahan is the only full-service facility in Alabama specializing in the diagnosis and treatment of the eye and one of only a few worldwide that is entirely devoted to advancements in ophthalmology. That reputation is supported by 16 operating rooms dedicated to eye surgery and a 24/7 eye emergency room that is the region’s only Level I Ocular Trauma Center. More than 11,000 surgeries are performed at UAB Callahan Eye Hospital each year, and we conduct more reconstructive eye procedures than any other facility in the world.
Our facility is home to more than two dozen ophthalmologists, many of whom are named among the top doctors in their fields nationally. Callahan is widely recognized for excellence in patient care, having consistently earned prestigious awards from health care consulting group Press Ganey, and in 2017 Callahan was named as one of the “100 Great Places to Work in Healthcare” by Becker’s Hospital Review.
Callahan also is known for pioneering developments in surgical instruments, devices, and procedures used by ophthalmologists across the globe. As part of the UAB Medicine academic medical center, Callahan is actively involved in ongoing research and clinical trials. Many of our ophthalmologists have received funding from prestigious research organizations and institutions and collaborate in clinical care to bring the latest in scientific discovery to our patients.
Related Conditions
This procedure may be used to treat or diagnose several different conditions. We have listed some of these conditions below for your convenience. Please note that this is not a comprehensive list and may vary depending on your specific diagnosis.
Related Treatments
Depending on your case and your physician’s assessment, your condition may be treated using one or more various procedures. Some of those procedures are listed below for your convenience. Please note that this is not a comprehensive list and may vary depending on your specific diagnosis.
More from UAB
Around the Web
LATEST HEADLINES
-
TxAccess Referral Portal
- Publish Date
- 5/19/22
-
What Women Should Know About Lung Cancer
- Publish Date
- 5/11/22
-
What Everyone Should Know About Hot Car Deaths
- Publish Date
- 5/11/22
-
UAB Medicine Employee Couple Juggle Premature Birth, Organ Transplant
- Publish Date
- 5/6/22
-
Brain Cancer: What You Need to Know
- Publish Date
- 5/6/22
-
A Silent Killer: How High Blood Pressure Hurts the Body
- Publish Date
- 5/6/22
-
Evusheld Provides Additional Protection for Immune-compromised Patients Against COVID-19
- Publish Date
- 5/5/22
-
UAB’s Cardiothoracic Surgery Unit has been Awarded the Beacon Award for Excellence by AACN
- Publish Date
- 4/28/22
-
Guinness World Records Names Longest Survivor of an Artificial Double Heart-Valve Replacement
- Publish Date
- 4/28/22
-
Women's Heart Health Virtual Support Group
- Publish Date
- 4/28/22